Patents by Inventor Chung-Yi Kung

Chung-Yi Kung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8501981
    Abstract: The invention relates to compounds of the formula I in which R1, R2, X, A, B, Z and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: August 6, 2013
    Assignee: SANOFI
    Inventors: Stephanie Hachtel, Juergen Dedio, Elisabeth DeFossa, Sven Grueneberg, Holger Heitsch, William Bock, Charlie Chen, Raymond Kosley, Chung-Yi Kung, Marcel Patek, Rosy Sher, Stephen Shimshock, Aleksandra Weichsel
  • Publication number: 20090227625
    Abstract: The invention relates to compounds of the formula I in which R1, R2, X, A, B, Z and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.
    Type: Application
    Filed: December 17, 2008
    Publication date: September 10, 2009
    Applicant: sanofi-aventis
    Inventors: Stephanie HACHTEL, Juergen DEDIO, Elisabeth DeFOSSA, Sven GRUENEBERG, Holger HEITSCH, William BOCK, Charlie CHEN, Raymond KOSLEY, Chung-Yi KUNG, Marcel PATEK, Rosy SHER, Stephen SHIMSHOCK, Aleksandra WEICHSEL
  • Patent number: 6461546
    Abstract: This invention describes a method of producing polymer powders from solution in a compatible solvent using a new device referred to as a microdroplets on demand generator (MODG). The embodiment of this invention is the MODG apparatus and its relevance as a method to extensive application in materials science and technology. Proof of concept is demonstrated using poly(ethylene) glycol polymer microparticles generated with the MODG and captured in a microparticle levitation device.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: October 8, 2002
    Assignees: UT-Battelle, Iowa State University Research Foundation, Inc.
    Inventors: Donald W. Noid, Joshua U. Otaigbe, Michael D. Barnes, Bobby G. Sumpter, Chung-Yi Kung